Think

Search This Blog

A Popular Test Claims to Boost I.V.F. Success. The Science Is Unclear.

December 18, 2021

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

I.V.F. patients are confronted with an increasing number of costly "add-ons." Some argue that more robust research is needed to support the effectiveness of such a test.

By AMY KLEIN | NYTimes Health | Disclosure

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

A Trans Researcher’s Pursuit of Better Data on Detransition

Kinnon MacKinnon leads the world’s largest study on people who stop or reverse their gender transitions, a group embroiled in intense political fights. Azeen Ghorayshi | NYTimes Health | Disclosure

He’s the F.D.A.’s Cancer Chief, Not a Fortune Teller

Dr. Richard Pazdur for 25 years has overseen innovations in the treatment of deadly diseases at the agency. Gina Kolata | NYTimes Health | Disclosure

Why Heat Waves of the Future May Be Even Deadlier Than Believed

The body’s cooling defenses fail at lower “wet bulb” temperatures than scientists had estimated. Clayton Dalton | NYTimes Health | Disclosure

Under a L.A. Freeway, a Psychiatric Rescue Mission

The crisis of homelessness is pushing American psychiatry to places it has not gone before — like sidewalk injections of antipsychotics. Ellen Barry and Rachel Bujalski | NYTimes Health | Disclosure

For Older Unmarried Couples, Caregiving Obligations Can Be Murky

What should be expected of an intimate partner when a companion suffers a health crisis? Seniors and their families increasingly confront the question. Paula Span | NYTimes Health | Disclosure

A Popular Test Claims to Boost I.V.F. Success. The Science Is Unclear.

I.V.F. patients are confronted with an increasing number of costly "add-ons." Some argue that more robust research is needed to support the effectiveness of such a test.

Comments

Post a Comment